Try our Advanced Search for more refined results

Expert Analysis

The Skinny On Skinny Labels

Law360, New York (September 8, 2011, 1:09 PM EDT) -- The law surrounding U.S. Food and Drug Administration section viii certifications is currently in flux due to recent decisions of the Federal Circuit, Novo Nordisk v. Caraco Pharm. Labs. Ltd. and AstraZeneca LP v. Apotex Inc. The importance of this area of law is highlighted by the amicus curiae briefs filed by the solicitor general and five major generic industry groups requesting that the U.S. Supreme Court grant certiorari in Novo Nordisk....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!